Search Results - "Bastien, Roy R. L."

PAM50 proliferation score as a predictor of weekly paclitaxel benefit in breast cancer by Martín, Miguel, Prat, Aleix, Rodríguez-Lescure, Álvaro, Caballero, Rosalía, Ebbert, Mark T. W., Munárriz, Blanca, Ruiz-Borrego, Manuel, Bastien, Roy R. L., Crespo, Carmen, Davis, Carole, Rodríguez, César A., López-Vega, José M., Furió, Vicente, García, Ana M., Casas, Maribel, Ellis, Matthew J., Berry, Donald A., Pitcher, Brandelyn N., Harris, Lyndsay, Ruiz, Amparo, Winer, Eric, Hudis, Clifford, Stijleman, Inge J., Tuck, David P., Carrasco, Eva, Perou, Charles M., Bernard, Philip S.

“…To identify a group of patients who might benefit from the addition of weekly paclitaxel to conventional anthracycline-containing chemotherapy as adjuvant…”
Get full text

Simultaneous detection of lung fusions using a multiplex RT-PCR next generation sequencing-based approach: a multi-institutional research study by Vaughn, Cecily P, Costa, José Luis, Feilotter, Harriet E, Petraroli, Rosella, Bagai, Varun, Rachiglio, Anna Maria, Marino, Federica Zito, Tops, Bastiaan, Kurth, Henriette M, Sakai, Kazuko, Mafficini, Andrea, Bastien, Roy R L, Reiman, Anne, Le Corre, Delphine, Boag, Alexander, Crocker, Susan, Bihl, Michel, Hirschmann, Astrid, Scarpa, Aldo, Machado, José Carlos, Blons, Hélène, Sheils, Orla, Bramlett, Kelli, Ligtenberg, Marjolijn J L, Cree, Ian A, Normanno, Nicola, Nishio, Kazuto, Laurent-Puig, Pierre

“…Gene fusion events resulting from chromosomal rearrangements play an important role in initiation of lung adenocarcinoma. The recent association of four…”
Get full text

PAM50 breast cancer subtyping by RT-qPCR and concordance with standard clinical molecular markers by Bastien, Roy R L, Rodríguez-Lescure, Álvaro, Ebbert, Mark T W, Prat, Aleix, Munárriz, Blanca, Rowe, Leslie, Miller, Patricia, Ruiz-Borrego, Manuel, Anderson, Daniel, Lyons, Bradley, Álvarez, Isabel, Dowell, Tracy, Wall, David, Seguí, Miguel Ángel, Barley, Lee, Boucher, Kenneth M, Alba, Emilio, Pappas, Lisa, Davis, Carole A, Aranda, Ignacio, Fauron, Christiane, Stijleman, Inge J, Palacios, José, Antón, Antonio, Carrasco, Eva, Caballero, Rosalía, Ellis, Matthew J, Nielsen, Torsten O, Perou, Charles M, Astill, Mark, Bernard, Philip S, Martín, Miguel

“…Many methodologies have been used in research to identify the "intrinsic" subtypes of breast cancer commonly known as Luminal A, Luminal B, HER2-Enriched…”
Get full text

Agreement in Risk Prediction Between the 21‐Gene Recurrence Score Assay (Oncotype DX®) and the PAM50 Breast Cancer Intrinsic Classifier™ in Early‐Stage Estrogen Receptor–Positive Breast Cancer by Kelly, Catherine M., Bernard, Philip S., Krishnamurthy, Savitri, Wang, Bailiang, Ebbert, Mark T.W., Bastien, Roy R.L., Boucher, Kenneth M., Young, Elliana, Iwamoto, Takayuki, Pusztai, Lajos

“…Purpose. To compare risk assignment by PAM50 Breast Cancer Intrinsic Classifier™ and Oncotype DX_Recurrence Score (RS) in the same population. Methods. RNA was…”
Get full text

Morphologic Characteristics and Mutational Analysis of Fumarate Hydratase Deficient Kidney and Smooth Muscle Tumors: A Reference Laboratory Experience by McMurtry, Valarie, Mahlow, Jonathan, Coleman, Joshua F, Deftereos, Georgios, Jattani, Rakhi, Bastien, Roy R.L, Durtschi, Jacob, Jarboe, Elke, Lomo, Lesley, Sirohi, Deepika

“…Objectives: Fumarate hydratase (FH)-deficient tumors can occur due to germline or somatic mutations and have distinctive morphologic features. The aims of this…”
Get full text

Prediction of Lung Cancer Histological Types by RT-qPCR Gene Expression in FFPE Specimens by Wilkerson, Matthew D, Schallheim, Jason M, Hayes, D. Neil, Roberts, Patrick J, Bastien, Roy R.L, Mullins, Michael, Yin, Xiaoying, Miller, C. Ryan, Thorne, Leigh B, Geiersbach, Katherine B, Muldrew, Kenneth L, Funkhouser, William K, Fan, Cheng, Hayward, Michele C, Bayer, Steven, Perou, Charles M, Bernard, Philip S

“…Lung cancer histologic diagnosis is clinically relevant because there are histology-specific treatment indications and contraindications. Histologic diagnosis…”
Get full text

Morphologic Characteristics and Mutational Analysis of Fumarate Hydratase Deficient Kidney and Smooth Muscle Tumors by McMurtry, Valarie, Mahlow, Jonathan, Coleman, Joshua F, Deftereos, Georgios, Jattani, Rakhi, Bastien, Roy R L, Durtschi, Jacob, Jarboe, Elke, Lomo, Lesley, Sirohi, Deepika

“…Fumarate hydratase (FH)-deficient tumors can occur due to germline or somatic mutations and have distinctive morphologic features. The aims of this study are…”
Get full text

Clinical validation of the Prosigna breast cancer prognostic gene signature assay on formalin-fixed paraffin embedded breast cancer tumors with comparison to standard molecular markers by Bastien, Roy R. L., Vaughn, Cecily, Elsberry, Danielle, Stijleman, Inge J., Bernard, Philip Seth

“…Abstract only…”
Get full text

Characterization of uncertainty in the classification of multivariate assays: application to PAM50 centroid-based genomic predictors for breast cancer treatment plans by Ebbert, Mark Tw, Bastien, Roy Rl, Boucher, Kenneth M, Martín, Miguel, Carrasco, Eva, Caballero, Rosalía, Stijleman, Inge J, Bernard, Philip S, Facelli, Julio C

“…Multivariate assays (MVAs) for assisting clinical decisions are becoming commonly available, but due to complexity, are often considered a high-risk approach…”
Get full text

Agreement in Risk Prediction Between the 21-Gene Recurrence Score Assay (Oncotype DX registered ) and the PAM50 Breast Cancer Intrinsic Classifier registered in Early-Stage Estrogen Receptor-Positive Breast Cancer by Kelly, Catherine M, Bernard, Philip S, Krishnamurthy, Savitri, Wang, Bailiang, Ebbert, Mark TW, Bastien, Roy RL, Boucher, Kenneth M, Young, Elliana, Iwamoto, Takayuki, Pusztai, Lajos

“…PURPOSE: To compare risk assignment by PAM50 Breast Cancer Intrinsic Classifier registered and Oncotype DX_Recurrence Score (RS) in the same population…”
Get full text